Porphyria cutanea tarda as the most common porphyria

Acta Dermatovenerologica Croatica

Volumn 15, Issue 4, 2007, Pages 254-263

  Bulat, Vedrana ^a   Lugović, Liborija ^a   Šitum, Mima ^a   Buljan, Marija ^a   Bradić, Lada ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Porphyria; Porphyria cutanea tarda; Porphyrin

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; COLESTYRAMINE; ERYTHROPOIETIN; HYDROXYCHLOROQUINE; IRON CHELATING AGENT; PORPHYRINOGEN; SUNSCREEN; UROPORPHYRINOGEN; UROPORPHYRINOGEN DECARBOXYLASE;

BLISTER; DISEASE CLASSIFICATION; EYE TOXICITY; GENE MUTATION; GENETIC ASSOCIATION; HEME SYNTHESIS; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; LEAD POISONING; LIVER TOXICITY; PATHOGENESIS; PHLEBOTOMY; PORPHYRIA; PORPHYRIA CUTANEA TARDA; REVIEW; SCLERODERMA; SKIN FRAGILITY; SKIN MANIFESTATION;

HUMANS; PORPHYRIA CUTANEA TARDA;

EID: 38149093239     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. nd edition. New York: Churchill Livingstone; 1996. pp. 731-8.
2. th edition. Edinburgh: Elsevier Limited; 2004. p. 347.
3. nd edition. Philadelphia: Elsevier Mosby; 2005. pp. 368-71.
4. Badminton MN, Elder GH. Molecular mechanisms of dominant expression in porphyria. J Inherit Metab Dis 2005;28:277-86.
5. nd completely revised edition. Berlin: Springer-Verlag; 2000. pp. 1309-26.
6. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J et al. Is hepatitis C infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-9.
7. Bickers DR, Poh-Fitzpatrick MB. Günther's disease and the changing complexion of human porphyria. Photodermatology 1986;3:315-6.
8. Bloomer JR. The liver in protoporphyria. Hepatology 1988;8:402-7.
9. Eales L, Day RS, Blekkenhorst GH. The clinical and biochemical features of variegate porphyria: an analysis of 300 case studies at Groote Schuur Hospital, Cape Town. Int J Biochem 1980;12:837-53.
10. Lim HW. Pathophysiology of cutaneous lesions in porphyrias. Semin Hematol 1989;26:114-9.
11. Lim HW, Gigli I, Wasserman SI. Differential effects of protoporphyrin and uroporphyrin on murine mast cells. J Invest Dermatol 1987;88:282-7.
12. Toback AC, Sassa S, Poh-Fitzpatrick MB, Schechter J, Zaider E. Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage. N Engl J Med 1987;316:645-50.
13. Nakahashi Y, Fujita H, Taketani S, Ishida N, Kappas A, Sassa S. The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria. Proc Natl Acad Sci USA 1992;89:281-5.
14. Cohen P. Porphyria cutanea tarda in human immunodeficiency virus-seropositive men: case report and literature review. J AIDS 1991;4:1112-7.
15. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, Deleo VA, Harber LC. Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients. Am J Med 1979;67:277-86.
16. Held JL, Sassa S, Kappas A, Harber LC. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. J Invest Dermatol 1989;93:332-4.
17. Garey JR, Hansen JL, Harrison LM, Kennedy JB, Kushner JP. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood 1989;73:892-5.
18. Garey JR, Harrison LM, Franklin KF, Metcalf KM, Radisky ES, Kushner JP. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest 1990;86:1416-22.
19. Garey JR, Hansen JL, Harrison LM, Kennedy JB, Kushner JP. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood 1989;73:892-5.
20. Cainelli T, Di Padova C, Marchesi L, Gori G, Rovagnati P, Podenzani SA et al. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda. Br J Dermatol 1983;108:593-600.
21. Ippen H. Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol 1977;14:253-62.
22. Anderson KE, Goeber DE, Carson RW, Lee SM, Stead RB. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on a long-term hemodialysis. N Engl J Med 1990;322:315-7.